AstraZeneca’s revenues came to a virtual standstill in 2010, with strong growth outside the US being offset by generic competition …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

